Clinical Trial Update: Antibody Production in Immune Disorders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for antibody production in immune disorders was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Deficiency

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Primary Immune Deficiency | Phase 4 | Status: TERMINATED